Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desvenlafaxine for Vascular Depression
NCT01974934Phase 4Unknown
- Sponsor
- Hotel-Dieu Grace Healthcare
- Start
- Dec 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of desvenlafaxine in vascular depression (VD), sponsored by Hotel-Dieu Grace Healthcare. Primary endpoint: Change in Geriatric Depression Scale Score at 12 weeks. Status: unknown.
02
Drugs
desvenlafaxine
03
Conditions
vascular depression (VD)
Beyond the preview
Go deeper on NCT01974934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01974934.